Cargando…
A New Approach to Imaging and Rapid Microbiome Identification for Prostate Cancer Patients Undergoing Radiotherapy
(1) Background: Little is known about the impact of urinary microflora, in particular, its effects on side effects after radiotherapy. The use of mass spectrometry identification method (MALDI) may bring a new look at the issue of the composition and significance of the urinary microbiome. This stud...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405325/ https://www.ncbi.nlm.nih.gov/pubmed/36009352 http://dx.doi.org/10.3390/biomedicines10081806 |
_version_ | 1784773853177708544 |
---|---|
author | Maślak, Ewelina Miśta, Wioletta Złoch, Michał Błońska, Dominika Pomastowski, Paweł Monedeiro, Fernanda Buszewski, Bogusław Mrochem-Kwarciak, Jolanta Bojarska, Katarzyna Gabryś, Dorota |
author_facet | Maślak, Ewelina Miśta, Wioletta Złoch, Michał Błońska, Dominika Pomastowski, Paweł Monedeiro, Fernanda Buszewski, Bogusław Mrochem-Kwarciak, Jolanta Bojarska, Katarzyna Gabryś, Dorota |
author_sort | Maślak, Ewelina |
collection | PubMed |
description | (1) Background: Little is known about the impact of urinary microflora, in particular, its effects on side effects after radiotherapy. The use of mass spectrometry identification method (MALDI) may bring a new look at the issue of the composition and significance of the urinary microbiome. This study aimed to use the mass spectrometry identification method (MALDI) to identify the microbiome of urine samples collected from 50 irradiated prostate cancer patients. (2) Methods: Blood and urine samples were collected before gold marker implantation, at the start and last day of radiotherapy, 1, 4 months after. Patients do not always collect the urine from the midstream; therefore, samples were collected from the first void and midstream in 12 patients for MALDI analysis; in the remaining 38 patients—from the midstream void for MALDI and biochemical analysis. (3) Results: Microorganisms were present in 140/181 urine samples. We found 33 different species 3G(−) and 30G(+). The most frequently isolated strains were: Staphylococcus haemolyticus, Staphylococcus epidermidis, Staphylococcus hominis, Enterococcus faecalis, and Micrococcus luteus. When comparing the type of urine samples, bacteria were more common in samples from the first-void urine than from the midstream one. The absence of bacteria was found in 12.2% of samples from the first-void urine and in 24.7% from the midstream. There was no difference in the total incidence of species between streams (p = 0.85). Before fiducial implantation, the total number of detected bacterial species was significantly higher in comparison to the end of radiotherapy (p = 0.038), indicating that the administered therapy resulted in depleting the local microbiome. One month after radiotherapy, an increase in the number of isolated bacteria was observed. The number of bacterial species in urine did not correlate with blood parameters. The presence of leukocytes (p = 0.013) and proteins (p = 0.004) in urine was related to a greater variety of bacteria found in urine specimens. (4) Conclusions: We obtained a similar spectrum of bacteria from the initial and middle urine streams. We also showed that there is a change in bacteria species affected by the treatment of prostate cancer patients, with both antibiotics before gold fiducial implantation and radiotherapy. |
format | Online Article Text |
id | pubmed-9405325 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94053252022-08-26 A New Approach to Imaging and Rapid Microbiome Identification for Prostate Cancer Patients Undergoing Radiotherapy Maślak, Ewelina Miśta, Wioletta Złoch, Michał Błońska, Dominika Pomastowski, Paweł Monedeiro, Fernanda Buszewski, Bogusław Mrochem-Kwarciak, Jolanta Bojarska, Katarzyna Gabryś, Dorota Biomedicines Article (1) Background: Little is known about the impact of urinary microflora, in particular, its effects on side effects after radiotherapy. The use of mass spectrometry identification method (MALDI) may bring a new look at the issue of the composition and significance of the urinary microbiome. This study aimed to use the mass spectrometry identification method (MALDI) to identify the microbiome of urine samples collected from 50 irradiated prostate cancer patients. (2) Methods: Blood and urine samples were collected before gold marker implantation, at the start and last day of radiotherapy, 1, 4 months after. Patients do not always collect the urine from the midstream; therefore, samples were collected from the first void and midstream in 12 patients for MALDI analysis; in the remaining 38 patients—from the midstream void for MALDI and biochemical analysis. (3) Results: Microorganisms were present in 140/181 urine samples. We found 33 different species 3G(−) and 30G(+). The most frequently isolated strains were: Staphylococcus haemolyticus, Staphylococcus epidermidis, Staphylococcus hominis, Enterococcus faecalis, and Micrococcus luteus. When comparing the type of urine samples, bacteria were more common in samples from the first-void urine than from the midstream one. The absence of bacteria was found in 12.2% of samples from the first-void urine and in 24.7% from the midstream. There was no difference in the total incidence of species between streams (p = 0.85). Before fiducial implantation, the total number of detected bacterial species was significantly higher in comparison to the end of radiotherapy (p = 0.038), indicating that the administered therapy resulted in depleting the local microbiome. One month after radiotherapy, an increase in the number of isolated bacteria was observed. The number of bacterial species in urine did not correlate with blood parameters. The presence of leukocytes (p = 0.013) and proteins (p = 0.004) in urine was related to a greater variety of bacteria found in urine specimens. (4) Conclusions: We obtained a similar spectrum of bacteria from the initial and middle urine streams. We also showed that there is a change in bacteria species affected by the treatment of prostate cancer patients, with both antibiotics before gold fiducial implantation and radiotherapy. MDPI 2022-07-27 /pmc/articles/PMC9405325/ /pubmed/36009352 http://dx.doi.org/10.3390/biomedicines10081806 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Maślak, Ewelina Miśta, Wioletta Złoch, Michał Błońska, Dominika Pomastowski, Paweł Monedeiro, Fernanda Buszewski, Bogusław Mrochem-Kwarciak, Jolanta Bojarska, Katarzyna Gabryś, Dorota A New Approach to Imaging and Rapid Microbiome Identification for Prostate Cancer Patients Undergoing Radiotherapy |
title | A New Approach to Imaging and Rapid Microbiome Identification for Prostate Cancer Patients Undergoing Radiotherapy |
title_full | A New Approach to Imaging and Rapid Microbiome Identification for Prostate Cancer Patients Undergoing Radiotherapy |
title_fullStr | A New Approach to Imaging and Rapid Microbiome Identification for Prostate Cancer Patients Undergoing Radiotherapy |
title_full_unstemmed | A New Approach to Imaging and Rapid Microbiome Identification for Prostate Cancer Patients Undergoing Radiotherapy |
title_short | A New Approach to Imaging and Rapid Microbiome Identification for Prostate Cancer Patients Undergoing Radiotherapy |
title_sort | new approach to imaging and rapid microbiome identification for prostate cancer patients undergoing radiotherapy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405325/ https://www.ncbi.nlm.nih.gov/pubmed/36009352 http://dx.doi.org/10.3390/biomedicines10081806 |
work_keys_str_mv | AT maslakewelina anewapproachtoimagingandrapidmicrobiomeidentificationforprostatecancerpatientsundergoingradiotherapy AT mistawioletta anewapproachtoimagingandrapidmicrobiomeidentificationforprostatecancerpatientsundergoingradiotherapy AT złochmichał anewapproachtoimagingandrapidmicrobiomeidentificationforprostatecancerpatientsundergoingradiotherapy AT błonskadominika anewapproachtoimagingandrapidmicrobiomeidentificationforprostatecancerpatientsundergoingradiotherapy AT pomastowskipaweł anewapproachtoimagingandrapidmicrobiomeidentificationforprostatecancerpatientsundergoingradiotherapy AT monedeirofernanda anewapproachtoimagingandrapidmicrobiomeidentificationforprostatecancerpatientsundergoingradiotherapy AT buszewskibogusław anewapproachtoimagingandrapidmicrobiomeidentificationforprostatecancerpatientsundergoingradiotherapy AT mrochemkwarciakjolanta anewapproachtoimagingandrapidmicrobiomeidentificationforprostatecancerpatientsundergoingradiotherapy AT bojarskakatarzyna anewapproachtoimagingandrapidmicrobiomeidentificationforprostatecancerpatientsundergoingradiotherapy AT gabrysdorota anewapproachtoimagingandrapidmicrobiomeidentificationforprostatecancerpatientsundergoingradiotherapy AT maslakewelina newapproachtoimagingandrapidmicrobiomeidentificationforprostatecancerpatientsundergoingradiotherapy AT mistawioletta newapproachtoimagingandrapidmicrobiomeidentificationforprostatecancerpatientsundergoingradiotherapy AT złochmichał newapproachtoimagingandrapidmicrobiomeidentificationforprostatecancerpatientsundergoingradiotherapy AT błonskadominika newapproachtoimagingandrapidmicrobiomeidentificationforprostatecancerpatientsundergoingradiotherapy AT pomastowskipaweł newapproachtoimagingandrapidmicrobiomeidentificationforprostatecancerpatientsundergoingradiotherapy AT monedeirofernanda newapproachtoimagingandrapidmicrobiomeidentificationforprostatecancerpatientsundergoingradiotherapy AT buszewskibogusław newapproachtoimagingandrapidmicrobiomeidentificationforprostatecancerpatientsundergoingradiotherapy AT mrochemkwarciakjolanta newapproachtoimagingandrapidmicrobiomeidentificationforprostatecancerpatientsundergoingradiotherapy AT bojarskakatarzyna newapproachtoimagingandrapidmicrobiomeidentificationforprostatecancerpatientsundergoingradiotherapy AT gabrysdorota newapproachtoimagingandrapidmicrobiomeidentificationforprostatecancerpatientsundergoingradiotherapy |